The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas
Open accessAbstract
Cushing disease is a condition in which the pituitary gland releases excessive adrenocorticotropic hormone (ACTH) as a result of an adenoma arising from the ACTH-secreting cells in the anterior pituitary. ACTH-secreting pituitary adenomas lead to hypercortisolemia and cause significant morbidity and mortality. Pituitary-directed medications are mostly ineffective, and new treatment options are needed. As these tumors express EGFR, we tested whether EGFR might provide a therapeutic target for Cushing disease. Here, we show that in surgically resected human and canine corticotroph cultured tumors, blocking EGFR suppressed expression of proopiomelanocortin (POMC), the ACTH precursor. In mouse corticotroph EGFR transfectants, ACTH secretion was enhanced, and EGF increased Pomc promoter activity, an effect that was dependent on MAPK. Blocking EGFR activity with gefitinib, an EGFR tyrosine kinase inhibitor, attenuated Pomc expression, inhibited corticotroph tumor cell proliferation, and induced apoptosis. As predominantly nuclear EGFR expression was observed in canine and human corticotroph tumors, we preferentially targeted EGFR to mouse corticotroph cell nuclei, which resulted in higher Pomc expression and ACTH secretion, both of which were inhibited by gefitinib. In athymic nude mice, EGFR overexpression enhanced the growth of explanted ACTH-secreting tumors and further elevated serum corticosterone levels. Gefitinib treatment decreased both tumor size and corticosterone levels; it also reversed signs of hypercortisolemia, including elevated glucose levels and excess omental fat. These results indicate that inhibiting EGFR signaling may be a novel strategy for treating Cushing disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
Mok, T. S., Wu, Y.-L., Thongprasert, S., Yang, C.-H., Chu, D.-T., Saijo, N., Sunpaweravong, P., Han, B., Margono, B., Ichinose, Y., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810699 · Cited by 8,261
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Nakayama, K., Ishida, N., Shirane, M., Inomata, A., Inoue, T., Shishido, N., Horii, I., Loh, D. Y., & Nakayama, K.-I. (1996) · Cell · doi:10.1016/s0092-8674(00)81237-4 · Cited by 1,547
Fero, M. L., Rivkin, M., Tasch, M., Porter, P., Carow, C. E., Firpo, E., Polyak, K., Tsai, L.-H., Broudy, V., Perlmutter, R. M., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81239-8 · Cited by 1,457
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors
Mellinghoff, I. K., Wang, M. Y., Vivanco, I., Haas-Kogan, D. A., Zhu, S., Dia, E. Q., Lu, K. V., Yoshimoto, K., Huang, J. H. Y., Chute, D. J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051918 · Cited by 1,442
Review of epidermal growth factor receptor biology
Herbst, R. S. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.11.041 · Cited by 1,390
Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27
Kiyokawa, H., Kineman, R. D., Manova-Todorova, K. O., Soares, V. C., Hoffman, E. S., Ono, M., Khanam, D., Hayday, A. C., Frohman, L. A., & Koff, A. (1996) · Cell · doi:10.1016/s0092-8674(00)81238-6 · Cited by 1,251
Newell-Price, J., Bertagna, X., Grossman, A. B., & Nieman, L. K. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68699-6 · Cited by 1,165
Nuclear localization of EGF receptor and its potential new role as a transcription factor
Lin, S.-Y., Makino, K., Xia, W., Matin, A., Wen, Y., Kwong, K. Y., Bourguignon, L., & Hung, M.-C. (2001) · Nature Cell Biology · doi:10.1038/ncb0901-802 · Cited by 1,064
Oldfield, E. H., Doppman, J. L., Nieman, L. K., Chrousos, G. P., Miller, D. L., Katz, D. A., Cutler, G. B., & Loriaux, D. L. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109263251301 · Cited by 866
Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement
Biller, B. M. K., Grossman, A. B., Stewart, P. M., Melmed, S., Bertagna, X., Bertherat, J., Buchfelder, M., Colao, A., Hermus, A. R., Hofland, L. J., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2734 · Cited by 853
Self-citationAcromegaly pathogenesis and treatment
Melmed, S. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39375 · Cited by 687
Self-citationLamolet, B., Pulichino, A.-M., Lamonerie, T., Gauthier, Y., Brue, T., Enjalbert, A., & Drouin, J. (2001) · Cell · doi:10.1016/s0092-8674(01)00282-3 · Cited by 546
Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway
Lo, H.-W., Hsu, S.-C., Ali-Seyed, M., Gunduz, M., Xia, W., Wei, Y., Bartholomeusz, G., Shih, J.-Y., & Hung, M.-C. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.05.007 · Cited by 544
Mechanisms for pituitary tumorigenesis: the plastic pituitary
Melmed, S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320401 · Cited by 456
Self-citationGefitinib Induces Apoptosis in the EGFRL858R Non–Small-Cell Lung Cancer Cell Line H3255
Tracy, S., Mukohara, T., Hansen, M., Meyerson, M., Johnson, B. E., & Jänne, P. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1905 · Cited by 374
Pivonello, R., De Martino, M. C., Cappabianca, P., De Leo, M., Faggiano, A., Lombardi, G., Hofland, L. J., Lamberts, S. W. J., & Colao, A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1533 · Cited by 328
Tyrosine phosphorylation controls PCNA function through protein stability
Wang, S.-C., Nakajima, Y., Yu, Y.-L., Xia, W., Chen, C.-T., Yang, C.-C., McIntush, E. W., Li, L.-Y., Hawke, D. H., Kobayashi, R., et al. (2006) · Nature Cell Biology · doi:10.1038/ncb1501 · Cited by 322
Nuclear EGFR contributes to acquired resistance to cetuximab
Li, C., Iida, M., Dunn, E. F., Ghia, A. J., & Wheeler, D. L. (2009) · Oncogene · doi:10.1038/onc.2009.234 · Cited by 313
Novel Prognostic Value of Nuclear Epidermal Growth Factor Receptor in Breast Cancer
Lo, H.-W., Xia, W., Wei, Y., Ali-Seyed, M., Huang, S.-F., & Hung, M.-C. (2005) · Cancer Research · doi:10.1158/0008-5472.338.65.1 · Cited by 290
Germline CDKN1B/p27Kip1 Mutation in Multiple Endocrine Neoplasia
Georgitsi, M., Raitila, A., Karhu, A., van der Luijt, R. B., Aalfs, C. M., Sane, T., Vierimaa, O., Mäkinen, M. J., Tuppurainen, K., Paschke, R., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2843 · Cited by 283
Boscaro, M., Ludlam, W. H., Atkinson, B., Glusman, J. E., Petersenn, S., Reincke, M., Snyder, P., Tabarin, A., Biller, B. M. K., Findling, J., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1008 · Cited by 279
Self-citationKovalovsky, D., Refojo, D., Liberman, A. C., Hochbaum, D., Páez-Pereda, M., Coso, O. A., Stalla, G. K., Holsboer, F., & ARZT, E. S. (2002) · Molecular Endocrinology · doi:10.1210/me.16.7.1638 · Cited by 277
Cohen, E. E. W., Kane, M. A., List, M. A., Brockstein, B. E., Mehrotra, B., Huo, D., Mauer, A. M., Pierce, C., Dekker, A., & Vokes, E. E. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1247 · Cited by 233
NeuroD1/β2 Contributes to Cell-Specific Transcription of the Proopiomelanocortin Gene
Poulin, G., Turgeon, B., & Drouin, J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.11.6673 · Cited by 231
Functional PPAR-γ receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas
Heaney, A. P., Fernando, M., Yong, W. H., & Melmed, S. (2002) · Nature Medicine · doi:10.1038/nm784 · Cited by 226
Self-citationTritos, N. A., Biller, B. M. K., & Swearingen, B. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.12 · Cited by 208
Lidhar, K. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.10.3823 · Cited by 196
Epidermal growth factor rapidly stimulates prolactin gene transcription
Murdoch, G. H., Potter, E., Nicolaisen, A. K., Evans, R. M., & Rosenfeld, M. G. (1982) · Nature · doi:10.1038/300192a0 · Cited by 193
Patronas, N., Bulakbasi, N., Stratakis, C. A., Lafferty, A., Oldfield, E. H., Doppman, J., & Nieman, L. K. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021438 · Cited by 185
Dwyer, A. J., Frank, J. A., Doppman, J. L., Oldfield, E. H., Hickey, A. M., Cutler, G. B., Loriaux, D. L., & Schiable, T. F. (1987) · Radiology · doi:10.1148/radiology.163.2.3562821 · Cited by 161
Xia, W., Wei, Y., Du, Y., Liu, J., Chang, B., Yu, Y., Huo, L., Miller, S. A., & Hung, M. (2008) · Molecular Carcinogenesis · doi:10.1002/mc.20504 · Cited by 151
Liu, N., Jiang, H., Ben-Shlomo, A., Wawrowsky, K., Fan, X., Lin, S., & Melmed, S. K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018091108 · Cited by 140
Self-citationRetinoic Acid as a Novel Medical Therapy for Cushing’s Disease in Dogs
Castillo, V. A., Giacomini, D., Páez-Pereda, M., Stalla, J., Labeur, M. S., Theodoropoulou, M., Holsboer, F., Grossman, A. B., Stalla, G. K., & ARZT, E. S. (2006) · Endocrinology · doi:10.1210/en.2006-0414 · Cited by 123
Theodoropoulou, M., Arzberger, T., Grübler, Y., Jaffrain‐Rea, M., Schlegel, J., Schaaf, L., Petrangeli, E., Losa, M., Stalla, G. K., & Pagotto, U. (2004) · Journal of Endocrinology · doi:10.1677/joe.1.05616 · Cited by 111
Bousquet, C., Zatelli, M. C., & Melmed, S. K. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11182 · Cited by 103
Self-citationMarti, U., Ruchti, C., Kämpf, J., Thomas, G. A., Williams, E. D., PETER, H. J., Gerber, H., & Bürgi, U. (2001) · Thyroid · doi:10.1089/105072501300042785 · Cited by 95
The T-box Factor Tpit Recruits SRC/p160 Co-activators and Mediates Hormone Action
Maira, M., Couture, C., Martelot, G. L., Pulichino, A.-M., Bilodeau, S., & Drouin, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305626200 · Cited by 88
Cooperation between Cyclin E and p27Kip1 in Pituitary Tumorigenesis
Roussel-Gervais, A., Bilodeau, S., Vallette-Kasic, S., Berthelet, F., Lacroix, A., Figarella‐Branger, D., Brue, T. C., & Drouin, J. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0091 · Cited by 79
Fukuoka, H., Cooper, O. B., Mizutani, J., Tong, Y., Ren, S.-G., Bannykh, S., & Melmed, S. K. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0353 · Cited by 71
Self-citationJenks, B. G. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2008.03620.x · Cited by 70
Öngürü, Ö., Scheithauer, B. W., Kovács, K., et al. (2004) · Modern Pathology · doi:10.1038/modpathol.3800118 · Cited by 66
Karalis, K. P., Venihaki, M., Zhao, J., van Vlerken, L. E., & Chandras, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313063200 · Cited by 62
Jehle, S., Walsh, J. E., Freda, P. U., & Post, K. D. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0979 · Cited by 56
Festuccia, C., Muzi, P., Millimaggi, D., Biordi, L. A., Gravina, G. L., Speca, S., Angelucci, A., Dolo, V., Vicentini, C., & Bologna, M. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.00986 · Cited by 54
Carbajal, L., Biswas, A., Niswander, L. M., Prizant, H., & Hammes, S. R. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0410 · Cited by 39
Moon, D., Kim, M.-O., Heo, M., Lee, J.-D., Choi, Y. H., & Kim, G. (2009) · Archives of Pharmacal Research · doi:10.1007/s12272-009-2002-7 · Cited by 39
Constitutive Somatostatin Receptor Activity Determines Tonic Pituitary Cell Response
Ben-Shlomo, A., Zhou, C., Pichurin, O., Chesnokova, V., Liu, N., Culler, M. D., & Melmed, S. K. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0361 · Cited by 33
Self-citationMechanisms of resistance to ErbB-targeted cancer therapeutics
Wang, Q., & Greene, M. I. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36260 · Cited by 31
Animal models of Cushing's disease
Kemppainen, R. J., & Peterson, M. E. (1994) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(94)90117-1 · Cited by 26
Corticotroph adenoma in the dog: Pathogenesis and new therapeutic possibilities
Castillo, V. A., & Gallelli, M. F. (2009) · Research in Veterinary Science · doi:10.1016/j.rvsc.2009.07.005 · Cited by 12
Cited by
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Consensus on diagnosis and management of Cushing's disease: a guideline update
Fleseriu, M., Auchus, R., Bancos, I., Ben-Shlomo, A., Bertherat, J., Biermasz, N. R., Boguszewski, C. L., Bronstein, M. D., Buchfelder, M., Carmichael, J. D., et al. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00235-7 · Cited by 953
Self-citationMutations in the deubiquitinase gene USP8 cause Cushing's disease
Reincke, M., Sbiera, S., Hayakawa, A., Theodoropoulou, M., Osswald, A., Beuschlein, F., Meitinger, T., Mizuno-Yamasaki, E., Kawaguchi, K., Saeki, Y., et al. (2015) · Nature Genetics · doi:10.1038/ng.3166 · Cited by 599
Raverot, G., Burman, P., McCormack, A., Heaney, A., Petersenn, S., Popovic, V., Trouillas, J., Dekkers, O. M., & _, _. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0796 · Cited by 595
Chatzellis, E., Alexandraki, K. I., Androulakis, I. I., & Kaltsas, G. (2015) · Neuroendocrinology · doi:10.1159/000371806 · Cited by 572
Metadata
- Authors
- Fukuoka, H., Cooper, O., Ben-Shlomo, A., Mamelak, A., Ren, S.-G., Bruyette, D., & Melmed, S.
- Venue
- Journal of Clinical Investigation
- Published
- 2011-12-01
- Volume
- 121
- Issue
- 12
- Pages
- 4712-4721
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2137987440
- Cited by
- 254
- References
- 52
- FWCI
- 10.12
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.